Development and validation of liquid chromatography–electrospray–tandem mass spectrometry method for determination of flibanserin in human plasma: Application to pharmacokinetic study on healthy female volunteers

A validated UPLC–MS/MS method for flibanserin in plasma and its pharmacokinetic interaction with bosentan in rats

(2018) Muzaffar Iqbal et al.   Bioanalysis

FDA Approval of Flibanserin — Treating Hypoactive Sexual Desire Disorder

(2016) Hylton V. Joffe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women

(2016) Loes Jaspers et al.   JAMA Internal Medicine

Determination of flibanserin and tadalafil in supplements for women sexual desire enhancement using high-performance liquid chromatography with tandem mass spectrometer, diode array detector and charged aerosol detector

(2014) Magdalena Poplawska et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder

(2013) James A. Simon et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Hypoactive Sexual Desire Disorder in Women: Treatment Options Beyond Testosterone and Approaches to Communicating with Patients on Sexual Health

(2013) Nicole M. Lodise   PHARMACOTHERAPY

New US FDA draft guidance on bioanalytical method validation versus current FDA and EMA guidelines: chromatographic methods and ISR

(2013) Dieter Zimmer   Bioanalysis

Isolation and structural elucidation of flibanserin as an adulterant in a health supplement used for female sexual performance enhancement

(2011) Min-Yong Low et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Developing Treatments for Female Sexual Dysfunction

(2010) R Jordan et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS